X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (21) 21
index medicus (16) 16
oncology (12) 12
female (11) 11
aged (7) 7
cancer (7) 7
expression (6) 6
mutation (6) 6
hematology (5) 5
hematology, oncology and palliative medicine (5) 5
middle aged (5) 5
tumors (5) 5
aged, 80 and over (4) 4
alzheimer's disease (4) 4
amyloid precursor protein (4) 4
antineoplastic agents - pharmacology (4) 4
biochemistry & molecular biology (4) 4
breast neoplasms - genetics (4) 4
cell line, tumor (4) 4
fusion proteins, bcr-abl - genetics (4) 4
gene expression (4) 4
leukemia, myelogenous, chronic, bcr-abl positive - genetics (4) 4
male (4) 4
oxidative stress (4) 4
adult (3) 3
amplification (3) 3
amyloid precursor protein secretases - metabolism (3) 3
analysis (3) 3
antineoplastic agents - therapeutic use (3) 3
apoptosis - drug effects (3) 3
aspartic acid endopeptidases - metabolism (3) 3
beta-secretase (3) 3
breast cancer (3) 3
cell cycle (3) 3
cells (3) 3
chemotherapy (3) 3
chronic myelogenous leukemia (3) 3
chronic myeloid leukemia (3) 3
colorectal cancer (3) 3
copy number (3) 3
flow cytometry (3) 3
imatinib (3) 3
immunohistochemistry (3) 3
in situ hybridization, fluorescence (3) 3
in-situ hybridization (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (3) 3
medicine (3) 3
molecular monitoring (3) 3
neurosciences (3) 3
polymerase chain reaction (3) 3
polymerase-chain-reaction (3) 3
protein kinase inhibitors - therapeutic use (3) 3
receptor, erbb-2 - metabolism (3) 3
resistance (3) 3
reverse transcriptase polymerase chain reaction (3) 3
signal transduction - drug effects (3) 3
treatment outcome (3) 3
young adult (3) 3
β-amyloid (3) 3
acute lymphoblastic-leukemia (2) 2
alzheimer disease - metabolism (2) 2
amyloid precursor protein secretases - genetics (2) 2
animals (2) 2
anticancer drugs (2) 2
aspartic acid endopeptidases - genetics (2) 2
bace1 (2) 2
breast neoplasms - metabolism (2) 2
breast neoplasms - pathology (2) 2
cell line (2) 2
cell proliferation (2) 2
cetuximab (2) 2
cholesterol (2) 2
cholesterol-synthesis (2) 2
chronic myeloid-leukemia (2) 2
chronic-phase (2) 2
cml (2) 2
cytochrome-c release (2) 2
cytogenetic analysis (2) 2
deoxyribonucleic acid--dna (2) 2
diagnosis (2) 2
disease progression (2) 2
dose-response relationship, drug (2) 2
drug resistance, neoplasm (2) 2
gamma-secretase (2) 2
gamma-secretase activity (2) 2
gene-expression profiles (2) 2
genetics & heredity (2) 2
genomes (2) 2
genomics (2) 2
harmonizing current methodology (2) 2
her2 (2) 2
imatinib mesylate (2) 2
inhibition (2) 2
internal medicine (2) 2
kinase domain mutations (2) 2
kras (2) 2
lung cancer (2) 2
medical education (2) 2
medical prognosis (2) 2
medical research (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 02/2013, Volume 54, Issue 2, pp. 342 - 352
Journal Article
Current Cancer Drug Targets, ISSN 1568-0096, 05/2012, Volume 12, Issue 4, pp. 316 - 328
Personalized medicine emphasizes the practice of considering individual patient characteristics as opposed to that centered on standards derived from... 
Molecular targeted therapy | KRAS | EGFR | Colorectal cancer | 1ST-LINE TREATMENT | PRIMARY TUMORS | STEM-CELLS | PHASE-III TRIAL | PANITUMUMAB | MUTATION STATUS | ONCOLOGY | EPIGENETIC INACTIVATION | CETUXIMAB PLUS IRINOTECAN | molecular targeted therapy | GENE COPY NUMBER | EXPRESSION
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2017, Volume 28, Issue suppl_7
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2015, Volume 10, Issue 11, p. e0142294
Journal Article
Current Cancer Drug Targets, ISSN 1568-0096, 03/2010, Volume 10, Issue 2, pp. 168 - 175
Lapatinib, a dual HER2 and EGFR tyrosine kinase inhibitor is highly active in HER2(+) breast cancer. However, its efficacy is limited by either primary or... 
Lapatinib | HER2 | Ras | MEK inhibitors | ras | HUMAN BREAST-CANCER | TRASTUZUMAB RESISTANCE | TUMORS | ONCOGENE | ONCOLOGY | PATHWAY | ERBB2 | TYROSINE KINASE INHIBITOR | HER-2/NEU | PRODUCT P21 | EXPRESSION
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 3777 - 3777
Abstract Abstract 3777 Recent laboratory studies have demonstrated that clarithromycin (CAM) is effective at increasing the sensitivity of chronic myeloid... 
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 05/2017, Volume 15, Issue 1, pp. 91 - 12
Background: Immunohistochemistry (IHC) and fluorescent-in situ hybridization (FISH) are standard methods to assess human epidermal growth factor receptor 2... 
REAL-TIME PCR | MEDICINE, RESEARCH & EXPERIMENTAL | DIGITAL PCR | CLINICAL-ONCOLOGY/COLLEGE | RT-PCR | HER-2/NEU GENE AMPLIFICATION | IN-SITU HYBRIDIZATION | FISH | AMERICAN-SOCIETY | RNA EXPRESSION | ONCOTYPE DX TEST | Immunohistochemistry | Breast Neoplasms - genetics | Receptor, ErbB-2 - genetics | Humans | Receptor, ErbB-2 - metabolism | Female | In Situ Hybridization, Fluorescence | ROC Curve | Reverse Transcriptase Polymerase Chain Reaction | Real-Time Polymerase Chain Reaction | Jaw | Copy number | Colleges & universities | Chains (polymeric) | Assaying | Stomach cancer | Proteins | Consortia | Breast carcinoma | Extraction | Dissection | Probes | Alzheimer's disease | Deoxyribonucleic acid--DNA | Elution | Sequences | Denaturation | Benign | Nucleic acids | Gene expression | Polymerase chain reaction | Amplification | Dilution | DNA microarrays | β-Amyloid | Protocol (computers) | Cell proliferation | Fluorescence | Population studies | Distortion | Chin | Quantitation | Biomedical materials | Specifications | Lesions | Stains | Buffers | Deoxyribonuclease | Statistical analysis | DNA probes | Incubation | Tumor cells | Breast cancer | Ribonucleic acid--RNA | Amyloid precursor protein | Computer programs | Gene amplification | Endopeptidase K | Acids | MicroRNAs | Reagents | Breast | Tumors | Cancer | Breast Cancer Cell Line SKBR3 | Equivocal Case
Journal Article
Blood, ISSN 0006-4971, 11/2010, Volume 116, Issue 21, pp. 4458 - 4458
Abstract Abstract 4458 Acquired resistance to Imatinib in advanced phase of CML has been associated with mutations in the kinase domain (KD) of BCR-ABL. We... 
Journal Article
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 09/2012, Volume 122, Issue 5, pp. 1023 - 1031
Journal Article
ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY, ISSN 0884-6812, 10/2018, Volume 40, Issue 5, pp. 222 - 230
OBJECTIVE: To develop a protocol for immunohistochemistry (IHC) to determine the Schlafen 11 (SLFN11) expression in formalin-fixed, paraffin-embedded (FFPE)... 
DIAGNOSIS | CELLS | serous high grade ovarian cancer | ovarian cancer | histological score | CANCER | Schlafen-11 | FAMILY | CELL BIOLOGY | PATHOGENESIS | ovarian neoplasms | SLFN11 | anti-SLFN11 antibody | CISPLATIN | BLOCKS | RESISTANCE | IRINOTECAN | immunohistochemistry
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2005, Volume 11, Issue 11, pp. 4259 - 4265
Journal Article